Tony Backert of Hilliard Lyons Named to 2017 Financial Times 401 Top Retirement Plan Advisers

By a News Reporter-Staff News Editor at Investment Weekly News -- Hilliard Lyons is pleased to announce that Tony Backert has been named to the 2017 edition of the Financial Times 401 Top Retirement Plan Advisers. The list recognizes the top financial advisers who specialize in serving defined contribution (DC) retirement plans.

Financial advisers from across the broker-dealer and RIA channels who met minimum of requirements applied for consideration. The applicants were then graded on seven criteria: (1) DC assets under management; (2) DC AUM growth rate; (3) specialization in DC plans; (4) years of experience; (5) DC plan participation rate; (6) advanced industry credentials; and (7) compliance record.

The final FT 401 represents an impressive cohort of elite advisers: the "average" adviser in this year's FT 401 has 19 years of experience advising DC plans and manages $1.6 billion in DC plan assets. The FT 401 advisers come from 38 states and Washington, D.C., and DC plans on average account for 74% of their total assets under management.

This honor is not indicative of the advisor's future performance. Neither advisors nor their parent firms pay a fee to the Financial Times to be included in the FT 401. ABOUT HILLIARD LYONS: Founded in 1854 and operating 70 offices in 12 states, Hilliard Lyons (hilliard.com) focuses on creating, preserving, and distributing clients' wealth. The firm specializes in planning issues that include education funding, business succession, retirement, and trusts and estates - to advise clients through life's financial challenges.

J.J.B. Hilliard, W.L. Lyons, LLC is a member of the New York Stock Exchange, FINRA, and SIPC. View source version on businesswire.com: http://www.businesswire.com/news/home/20170928005207/en/

Keywords for this news article include: Hilliard Lyons, Finance and Investment.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC